Baijin Life Science Holdings Limited
MNNGF
$0.08
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -37.40K | -745.30K | -1.45M | -1.20M | -952.20K |
| Total Depreciation and Amortization | 854.70K | 751.20K | 647.60K | 446.90K | 246.70K |
| Total Amortization of Deferred Charges | -93.10K | 99.40K | 292.10K | 292.10K | 292.10K |
| Total Other Non-Cash Items | -265.20K | -755.30K | -1.25M | -1.79M | -2.33M |
| Change in Net Operating Assets | -4.38M | -2.24M | -92.90K | 913.10K | 1.92M |
| Cash from Operations | -3.92M | -2.89M | -1.85M | -1.34M | -825.90K |
| Capital Expenditure | -314.20K | -192.80K | -71.40K | -47.10K | -22.90K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 230.00K | 460.20K | 460.20K | 460.20K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 205.30K | 182.20K | 159.00K | 164.10K | 169.10K |
| Cash from Investing | -109.00K | 219.30K | 547.80K | 577.20K | 606.50K |
| Total Debt Issued | 8.56M | 7.66M | 6.76M | 4.49M | 2.22M |
| Total Debt Repaid | -6.40M | -3.73M | -1.06M | -1.10M | -1.14M |
| Issuance of Common Stock | 40.22M | 26.78M | 13.33M | 6.67M | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -966.00K | -774.50K | -583.00K | -418.50K | -254.00K |
| Cash from Financing | 5.32M | 3.84M | 2.36M | 1.23M | 104.70K |
| Foreign Exchange rate Adjustments | -17.40K | -336.20K | -655.20K | -486.00K | -317.20K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1.27M | 835.50K | 402.40K | -15.30K | -432.00K |